Top Biotechnology companies in United States by Free Cash Flow Per Share

This ranking features the top 491 Biotechnology companies in United States ranked by Free Cash Flow Per Share, averaging a Free Cash Flow Per Share of USD -9.43, for January 15, 2025.

United States

Biotechnology

#	Name	Free Cash Flow Per Share	Reported Date	Stock Price	Change	Country
1	Regeneron Pharmaceuticals, Inc. 1 REGN	USD 31.38	Sept. 30, 2024	USD 690.87	-3.63%	United States
2	Thermo Fisher Scientific Inc. 2 TMO	USD 20.29	Sept. 28, 2024	USD 556.99	0.27%	United States
3	United Therapeutics Corporation 3 UTHR	USD 19.63	Sept. 30, 2024	USD 364.70	0.50%	United States
4	Biogen Inc. 4 BIIB	USD 12.17	Sept. 30, 2024	USD 143.06	-4.74%	United States
5	Amgen Inc. 5 AMGN	USD 11.72	Sept. 30, 2024	USD 267.10	-1.14%	United States
6	Charles River Laboratories International, Inc. 6 CRL	USD 10.90	Sept. 28, 2024	USD 178.08	-6.34%	United States
7	IQVIA Holdings Inc. 7 IQV	USD 10.77	Sept. 30, 2024	USD 197.96	-3.26%	United States
8	Laboratory Corporation of America Holdings 8 LH	USD 10.01	Sept. 30, 2024	USD 234.50	0.17%	United States
9	AbbVie Inc. 9 ABBV	USD 8.84	Sept. 30, 2024	USD 175.55	-0.67%	United States
10	Stryker Corporation 10 SYK	USD 8.42	Sept. 30, 2024	USD 362.80	0.50%	United States
11	Bio-Rad Laboratories, Inc. 11 BIO	USD 7.85	Sept. 30, 2024	USD 342.23	-2.69%	United States
12	Gilead Sciences, Inc. 12 GILD	USD 7.56	Sept. 30, 2024	USD 91.00	1.18%	United States
13	Danaher Corporation 13 DHR	USD 6.81	Sept. 27, 2024	USD 237.62	-0.94%	United States
14	Bristol-Myers Squibb Company 14 BMY	USD 6.81	Sept. 30, 2024	USD 55.74	0.69%	United States
15	Mesa Laboratories, Inc. 15 MLAB	USD 6.63	Sept. 30, 2024	USD 131.05	-0.04%	United States
16	Lantheus Holdings, Inc. 16 LNTH	USD 6.55	Sept. 30, 2024	USD 92.62	-2.15%	United States
17	Zoetis Inc. 17 ZTS	USD 5.06	Sept. 30, 2024	USD 164.41	-1.15%	United States
18	Balchem Corporation 18 BCPC	USD 5.03	Sept. 30, 2024	USD 158.62	1.47%	United States
19	Agilent Technologies, Inc. 19 A	USD 4.72	Oct. 31, 2024	USD 143.43	1.04%	United States
20	Revvity, Inc. 20 RVTY	USD 4.58	Sept. 29, 2024	USD 120.73	-1.61%	United States
21	Pacira BioSciences, Inc. 21 PCRX	USD 4.18	Sept. 30, 2024	USD 20.55	-2.74%	United States
22	Royalty Pharma plc 22 RPRX	USD 4.02	Sept. 30, 2024	USD 30.03	0.13%	United States
23	Assembly Biosciences, Inc. 23 ASMB	USD 3.98	Sept. 30, 2024	USD 14.74	-1.01%	United States
24	Harmony Biosciences Holdings, Inc. 24 HRMY	USD 3.85	Sept. 30, 2024	USD 36.42	-0.08%	United States
25	ANI Pharmaceuticals, Inc. 25 ANIP	USD 3.83	Sept. 30, 2024	USD 54.16	0.43%	United States
26	Protagonist Therapeutics, Inc. 26 PTGX	USD 3.75	Sept. 30, 2024	USD 36.67	-1.26%	United States
27	Amphastar Pharmaceuticals, Inc. 27 AMPH	USD 3.51	Sept. 30, 2024	USD 38.48	1.48%	United States
28	Illumina, Inc. 28 ILMN	USD 3.43	Sept. 29, 2024	USD 136.48	-5.37%	United States
29	Radius Health, Inc. 29 RDUS	USD 3.32	Nov. 30, 2023	USD 11.35	-0.53%	United States
30	Halozyme Therapeutics, Inc. 30 HALO	USD 3.08	Sept. 30, 2024	USD 53.83	-0.57%	United States
31	Corteva, Inc. 31 CTVA	USD 2.74	Sept. 30, 2024	USD 60.89	1.60%	United States
32	Emergent BioSolutions Inc. 32 EBS	USD 2.63	Sept. 30, 2024	USD 9.36	-0.53%	United States
33	Fortrea Holdings Inc. 33 FTRE	USD 2.48	Sept. 30, 2024	USD 17.64	-3.66%	United States
34	Repligen Corporation 34 RGEN	USD 2.35	Sept. 30, 2024	USD 156.55	-1.19%	United States
35	Globus Medical, Inc. 35 GMED	USD 2.16	Sept. 30, 2024	USD 88.18	1.15%	United States
36	Krystal Biotech, Inc. 36 KRYS	USD 2.04	Sept. 30, 2024	USD 142.64	-5.10%	United States
37	Catalyst Pharmaceuticals, Inc. 37 CPRX	USD 1.63	Sept. 30, 2024	USD 22.19	-0.09%	United States
38	BioMarin Pharmaceutical Inc. 38 BMRN	USD 1.59	Sept. 30, 2024	USD 63.81	-4.75%	United States
39	Bio-Techne Corporation 39 TECH	USD 1.55	Sept. 30, 2024	USD 74.73	-2.21%	United States
40	Castle Biosciences, Inc. 40 CSTL	USD 1.46	Sept. 30, 2024	USD 25.46	-2.64%	United States
41	Pfizer Inc. 41 PFE	USD 1.45	Sept. 29, 2024	USD 26.41	-1.46%	United States
42	Exelixis, Inc. 42 EXEL	USD 1.43	Sept. 27, 2024	USD 35.65	0.99%	United States
43	Corcept Therapeutics Incorporated 43 CORT	USD 1.39	Sept. 30, 2024	USD 51.66	1.18%	United States
44	DexCom, Inc. 44 DXCM	USD 1.37	Sept. 30, 2024	USD 79.17	-0.84%	United States
45	ACADIA Pharmaceuticals Inc. 45 ACAD	USD 1.23	Sept. 30, 2024	USD 16.90	-5.59%	United States
46	First Advantage Corporation 46 FA	USD 1.13	Sept. 30, 2024	USD 17.21	-1.54%	United States
47	Avantor, Inc. 47 AVTR	USD 1.10	Sept. 30, 2024	USD 21.72	-1.36%	United States
48	Bruker Corporation 48 BRKR	USD 1.07	Sept. 30, 2024	USD 61.26	-2.69%	United States
49	biote Corp. 49 BTMD	USD 1.03	Sept. 30, 2024	USD 5.67	2.35%	United States
50	SIGA Technologies, Inc. 50 SIGA	USD 1.00	Sept. 30, 2024	USD 6.33	4.46%	United States

1 2 3 4 … 10

Frequently Asked Questions

Which Biotechnology company in United States has the highest Free Cash Flow Per Share ?

The Biotechnology company in United States with the highest Free Cash Flow Per Share is Regeneron Pharmaceuticals, Inc. (NasdaqGS: REGN) at USD 31.38.
Which Biotechnology company in United States has the lowest Free Cash Flow Per Share ?

The Biotechnology company in United States with the lowest Free Cash Flow Per Share is Inovio Pharmaceuticals, Inc. (NasdaqCM: INO) at USD -3,330.16.

What are the top 10 Biotechnology companies in United States by Free Cash Flow Per Share ?

The top 10 Biotechnology companies in United States by Free Cash Flow Per Share are Regeneron Pharmaceuticals, Inc., Thermo Fisher Scientific Inc., United Therapeutics Corporation, Biogen Inc., Amgen Inc., Charles River Laboratories International, Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, AbbVie Inc. and Stryker Corporation.
What are the bottom 10 Biotechnology companies in United States by Free Cash Flow Per Share ?

The bottom 10 Biotechnology companies in United States by Free Cash Flow Per Share are Inovio Pharmaceuticals, Inc., Cingulate Inc., Palisade Bio, Inc., Singular Genomics Systems, Inc., Tharimmune, Inc., Cidara Therapeutics, Inc., Allarity Therapeutics, Inc., ZyVersa Therapeutics, Inc., Homology Medicines, Inc. and Galecto, Inc..